Viewing Study NCT00522951

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 11:51 PM
Ignite Modification Date: 2026-03-11 @ 10:49 AM
Study NCT ID: NCT00522951
Status: COMPLETED
Last Update Posted: 2017-08-28
First Post: 2007-08-29
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: SH L 562BB Phase II/III Dose Justification and Gadoteridol-controlled Comparative Study
Sponsor: Bayer
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Brain Metastases View
Keywords:

Keywords

Keyword Brief Keyword Text View
None MRI View
None Brain Metastasis View
None Gadolinium View
None Imaging View
None Diagnostic Agent View